Document:

exv4w12

 

Exhibit 4.12

REGISTRATION RIGHTS, LOCK UP

AND STANDSTILL AGREEMENT

     This Registration Rights, Lock Up And Standstill Agreement (this “Agreement”) is made
and entered into as of January 10, 2007, by and among UCBH Holdings, Inc., a Delaware corporation
registered under the Bank Holding Company Act of 1956, as amended (“UCBH”), CAB International
Holding Limited, a British Virgin Islands company (the “Company”) and Dr. Paul Shi H. Huang, the
sole holder of all of the issued and outstanding capital stock of the Company (“Dr. Huang”).

RECITALS

     Whereas, UCBH, UCB Merger II, LLC, a Delaware limited liability company and a wholly
owned subsidiary of UCBH (“Buyer”), the Company, CAB Holding LLC, a Delaware limited liability
company and a wholly owned subsidiary of the Company (“CAB LLC”) and Dr. Huang have entered into
that certain Agreement and Plan of Merger, dated as of even date herewith (the “Merger Agreement”);

     Whereas, pursuant to the terms of the Merger Agreement, CAB LLC will merge with and
into Buyer (the “Merger”), Buyer will be the surviving limited liability company and the Company,
sole member of CAB LLC, will receive Merger consideration comprised of cash and newly issued shares
of common stock of UCBH, par value $0.01 per share (the “Common Stock”), as a result of the Merger;

     Whereas, UCBH desires to provide the registration rights set forth in this Agreement
with respect to the Registrable Securities (as defined below) in order to induce the Company, CAB
LLC and Dr. Huang to enter into the Merger Agreement, and to agree to certain “lock up” and
“standstill” restrictions set forth in this Agreement with respect to the Registrable Securities;
and

     Whereas, in order to induce UCBH and Buyer to enter into the Merger Agreement and to
induce UCBH to provide the registration rights set forth in this Agreement, the Company and Dr.
Huang desire to agree to certain “lock up” and “standstill” restrictions with respect to the
Registrable Securities on the terms and conditions more fully set forth herein (the Company and Dr.
Huang collectively and jointly and severally are referred to herein as the “Holder”).

AGREEMENT

     Now, Therefore, in consideration of the foregoing and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree
hereto as follows:

          SECTION 1. DEFINITIONS

     1.1 Definitions. As used in this Agreement, the following terms shall have the following
meanings:

          (a) “1934 Act” shall mean the Securities Exchange Act of 1934, as amended.

          (b) “Act” shall mean the Securities Act of 1933, as amended.

          (c) “Closing Date” shall have the same meaning set forth in the Merger Agreement.

          (d) “Common Stock” shall have the meaning set forth in the Recitals above.

 

 

          (e) “Form S-3” shall mean Form S-3 promulgated under the Act as in effect on the date hereof
or any registration form under the Act subsequently adopted by the SEC which permits inclusion or
incorporation of substantial information by reference to other documents filed by UCBH with the SEC
before and after the effective date of the registration statement on such form.

          (f) The terms “register,” “registered,” and “registration” refer to a registration effected by
preparing and filing a registration statement or similar document in compliance with the Act, and
the declaration or ordering of effectiveness (or deemed effectiveness) of such registration
statement or document.

          (g) “Registrable Securities” mean (i) the shares of Common Stock issued to the Company
pursuant to Section 1.5 of the Merger Agreement, and (ii) any shares of Common Stock issued as a
dividend, stock split or other distribution with respect to or in exchange for or in replacement of
the shares referred to in Section 1.1(g)(i) above; provided, however, that Registrable Securities
shall not include any securities described in Sections 1.1(g)(i) or 1.1(g)(ii) above which (A) have
been sold to the public either pursuant to the Shelf Registration Statement or pursuant to Rule 144
under the Act or (B) are subject to any Transfer (as defined in Section 3.1 of this Agreement)
other than as permitted under Section 3 of this Agreement.

          (h) “Registration Expenses” shall mean the reasonable expenses incident to performance of or
compliance by UCBH with Section 2 of this Agreement, including (i) all SEC and stock exchange
registration and filing fees, (ii) all fees and expenses of complying with securities or blue sky
laws, (iii) all printing expenses, (iv) all fees and expenses incurred in connection with the
listing of Registrable Securities on the Nasdaq Global Select Market and all rating agency fees,
and (v) the fees and disbursements of counsel for UCBH and of its independent public accountants,
including the expenses of any special audits and/or comfort letters required by or incident to such
performance and compliance, but excluding underwriting discounts, selling commissions, fees or
other compensation payable to placement agents, fees and expenses of underwriters and/or placement
agents (including legal fees) and transfer taxes, if any.

          (i) “SEC” shall mean the United States Securities and Exchange Commission.

          (j) “Shelf Registration Statement” shall mean a “shelf” registration statement on Form S-3
filed by UCBH that covers the resale by the Company of all Registrable Securities held by the
Company at the time that such registration statement first becomes effective or is declared by the
SEC to be effective under the Act on a delayed or continuous basis under Rule 415 under the Act, or
any similar rule that may be adopted by the SEC, and all amendments and supplements to such
registration statement, including post-effective amendments, in each case including the prospectus
contained therein, all exhibits thereto and any document incorporated by reference therein.

          SECTION 2. REGISTRATION RIGHTS

     2.1 Shelf Registration.

          (a) By no later than twenty (20) days prior to the anticipated Closing Date, UCBH shall
prepare and file the Shelf Registration Statement with the SEC. UCBH shall use its commercially
reasonable efforts to cause the Shelf Registration Statement to become effective or to be declared
by the SEC to be effective as soon as practicable following its filing. After the Shelf
Registration Statement becomes effective, UCBH shall keep the Shelf Registration Statement
effective through the earliest to occur of (i) the second (2nd) anniversary of the
Closing Date and (ii) the date on which all Registrable Securities covered by the Shelf
Registration Statement have ceased to be Registrable Securities (the

2

 

“Shelf Effective Period”). If the Merger does not occur within ninety (90) days after filing
of the Shelf Registration Statement, UCBH has the right to withdraw the Shelf Registration
Statement; provided that once the anticipated Closing Date is determined after the withdrawal, UCBH
shall file the Registration Statement with the SEC by no later than 20 days prior to such
anticipated Closing Date.

          (b) UCBH shall notify the Company when the Shelf Registration Statement is available for offer
and sale of Registrable Securities. Holder agrees not to make any offer or sale under the Shelf
Registration Statement until the availability of the Shelf Registration Statement has been
confirmed in writing to Company by UCBH and, then, (i) only at such time as Holder has not been
informed in writing by UCBH that (A) any required supplement, amendment or other filings that are
required to be made under the Act have not been made in compliance with the Act and (B) there is
any suspension or cessation of offers and sales of the Registrable Securities pursuant to Section
2.6 below, and (ii) only pursuant to and in accordance with the lock up provisions of Section 3.1
below. Holder agrees to furnish to UCBH such information as UCBH may from time to time reasonably
request and as shall be reasonably required in connection with any distribution of Registrable
Securities.

          (c) The Shelf Registration Statement shall not be available for distribution of Registrable
Securities by Holder, UCBH shall have no obligation to facilitate any offer or sale of Registrable
Securities by Holder under the Shelf Registration Statement, and Holder shall not effect any offer
or sale of Registrable Securities under the Shelf Registration Statement:

               (i) During any Suspension Period or other cessation of offers and sales of Registrable
Securities as provided in Section 2.6 below;

               (ii) With respect to any Transfer that is not permitted under Section 3 of this Agreement;

               (iii) To the extent Holder proposes to distribute any Registrable Securities by means of an
underwritten offering;

               (iv) In any particular jurisdiction in which the UCBH would be required to execute a general
consent to service of process in effecting such registration, qualification, or compliance, unless
UCBH is already subject to service in such jurisdiction and except as may be required by the Act.

          (d) The obligations of UCBH under Section 2 of this Agreement shall be suspended during any
period that (i) UCBH is not entitled to use Form S-3 to register resales of its securities or (ii)
sales of Registrable Securities by Holder pursuant to the Shelf Registration Statement would not
meet the requirements of Form S-3 or Rule 415 under the Act.

     2.2 Expenses. UCBH will pay all Registration Expenses and Holder will pay all other expenses
related to Company’s sale of Registrable Securities.

     2.3 Obligations of UCBH. UCBH shall, subject to the terms and conditions hereof, use its
commercially reasonable efforts to:

          (a) Prepare and file with the SEC the Shelf Registration Statement, and use commercially
reasonable efforts to cause such registration statement to become effective and to keep such
registration statement effective as provided in Section 2.1(a) above;

3

 

          (b) Prepare and file, as expeditiously as reasonably practicable, with the SEC such amendments
and supplements to the Shelf Registration Statement and the prospectus used in connection with such
registration statement as may be necessary to comply with the provisions of the Act;

          (c) Furnish to the Company such numbers of copies of a prospectus, including a preliminary
prospectus, with respect to the Shelf Registration Statement in conformity with the requirements of
the Act;

          (d) Register and qualify the securities covered by the Shelf Registration Statement under such
blue sky laws of such states of the United States as shall be reasonably requested by the Company;
provided, however, that UCBH shall not be required in connection therewith or as a condition
thereto to qualify to do business or to file a general consent to service of process in any such
states or jurisdictions;

          (e) Notify the Company at any time that UCBH has knowledge that a prospectus relating to the
Shelf Registration Statement is required to be delivered under the Act of the happening of any
event as a result of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a material fact required
to be stated therein or necessary to make the statements therein not misleading in the light of the
circumstances then existing;

          (f) Subject to the provisions of Section 2.6 below, amend or supplement any such prospectus in
order to cause such prospectus not to include any untrue statement of material fact required to be
stated therein or necessary to make the statements therein not misleading in light of the
circumstances then existing;

          (g) Cause Registrable Securities covered by the Shelf Registration Statement to be listed on
the Nasdaq Global Select Market and provide the Company with information regarding the transfer
agent and the CUSIP number for such Registrable Securities; and

          (h) Notify the Company of (i) the effectiveness of the Shelf Registration Statement, (ii) the
filing of any post-effective amendments to such registration statement, or (iii) the filing of a
supplement to such registration statement; provided, however, that this requirement shall not apply
to periodic reports, other reports and proxy statements required to be filed by UCBH.

     2.4 Form S-3 Eligibility. UCBH represents and warrants as of the date hereof that it meets
the requirements for the use of Form S-3 for registration for the resale of the Registrable
Securities by the Company. UCBH agrees to use its commercially reasonable efforts to file all
reports required to be filed by UCBH with the SEC in a timely manner so as to remain eligible for
the use of Form S-3. In the event UCBH is no longer eligible to use Form S-3 (or any successor
form), UCBH shall satisfy its registration obligations hereunder pursuant to another available
registration statement form reasonably acceptable to the Company.

     2.5 Reports under the 1934 Act. With a view to making available to the Company the benefits
of Rule 144 (or any successor rule) and any other rule or regulation of the SEC that may at any
time permit the Company to sell Registrable Securities to the public without registration, UCBH
shall use commercially reasonable efforts to (a) make and keep public information available, as
those terms are understood and defined in Rule 144, until the earlier of (i) six months after such
date as all Registrable Securities may be resold pursuant to Rule 144(k) or any other rule of
similar effect or (ii) such date as all of Registrable Securities shall have been resold; (b) file
with the SEC in a timely manner all reports and other documents required to be filed by UCBH under
the 1934 Act; (c) furnish to the Company upon request, as long as the Company owns any Registrable
Securities, (1) a written statement by UCBH that UCBH has complied with the reporting requirements
of the 1934 Act, (2) a copy of UCBH’s most recent

4

 

Annual Report on Form 10-K or Quarterly Report on Form 10-Q; and (3) such other reports and
public documents as the Company may reasonably request in order to avail itself of any rule or
regulation of the SEC allowing it to sell Registrable Securities without registration.

     2.6 Suspension Periods. If disclosure of information in an amendment to the Shelf
Registration Statement and/or in a supplement to the prospectus included therein is required so
that such prospectus shall not include an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein not
misleading in light of the circumstances then existing, and if an executive officer of UCBH
determines in good faith at any time after consultation with counsel that such disclosure of any
such information would be materially detrimental to UCBH, then UCBH shall be permitted to delay
filing such amendment or supplement for a period of time not to exceed forty-five (45) consecutive
days or ninety (90) days in any rolling twelve-month period (each such period, a “Suspension
Period”) by providing written notice of such Suspension Period to the Company. Upon receiving
written notice of a Suspension Period Holder shall immediately cease (and shall cause its agents or
brokers to immediately cease) all offers and sales of Registrable Securities pursuant to the Shelf
Registration Statement. UCBH will promptly notify the Company in writing upon the termination of
any Suspension Period. In addition, and without any limitation of the foregoing, if at any time,
in UCBH’s good faith determination after consultation with counsel, that there is a substantial
risk that the offer or sale by Holder of any Registrable Securities pursuant to any registration
statement would result in a violation of the Act, the anti-fraud provisions of the 1934 Act or
other applicable law, then Holder shall, upon written notice to Company from UCBH, immediately
cease (and shall cause its agents or brokers to immediately cease) all offers and sales of
Registrable Securities under any registration statement until further notice from UCBH.

     2.7 Indemnification.

          (a) To the extent permitted by law, UCBH will indemnify and hold harmless the Company, each of
its officers and directors and each person, if any, who controls the Company within the meaning of
the Act or the 1934 Act, against any losses, claims, damages, or liabilities (joint or several) to
which they may become subject, insofar as such losses, claims, damages, or liabilities (or actions
in respect thereof) arise out of or are based upon any of the following statements, omissions or
violations (collectively, a “Violation”): (i) any untrue statement or alleged untrue statement of
a material fact contained in the Shelf Registration Statement, including any preliminary prospectus
or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission
or alleged omission to state in the shelf Registration Statement, including any preliminary
prospectus or final prospectus contained therein or any amendments or supplements thereto, a
material fact required to be stated therein, or necessary to make the statements therein not
misleading, (iii) any untrue statement or alleged untrue statement of a material fact contained in
any Issuer Free Writing Prospectus (as defined below), or any omission or alleged omission to state
therein a material fact necessary in order to make the statements therein not misleading, or (iv)
any violation or alleged violation by UCBH of the Act, the 1934 Act, any state securities law or
any rule or regulation promulgated under the Act, the 1934 Act or any state securities law in
connection with a registration effected pursuant to the terms of this Agreement; and UCBH will pay
to the Company, each of its officers, directors or controlling person, any legal or other expenses
reasonably incurred by them in connection with investigating or defending any such loss, claim,
damage, liability or action; provided, however, that the indemnity agreement contained in this
Section 2.7(a) shall not apply to amounts paid in settlement of any such loss, claim, damage,
liability or action if such settlement is effected without the consent of UCBH, which consent shall
not be unreasonably withheld, conditioned or delayed, nor shall UCBH be liable in any such case for
any such loss, claim, damage, liability or action to the extent that it arises out of or is based
upon a Violation which occurs in reliance upon and in conformity with written information furnished
expressly for use in connection with such registration by the Company or any underwriter or
controlling person thereof; and

5

 

provided, further, that the indemnity agreement contained in this Section 2.7(a) shall not
apply to, nor shall UCBH have any other liability elsewhere under this Agreement with respect to,
any sale of Registrable Securities by Holder under any registration statement with respect to which
the Company has not received confirmation within ten (10) business days prior to the date of such
sale that such registration statement is available to cover such sale. For purposes of this
Section 2.7(a), “Issuer Free Writing Prospectus” shall mean any “issuer free writing prospectus,”
as defined in Rule 433 under the Act.

          (b) To the extent permitted by law, Holder will indemnify and hold harmless UCBH, each of its
directors, officers and each person, if any, who controls UCBH within the meaning of the Act, any
underwriter, each of its officers, directors and partners, and any controlling person of any such
underwriter, against any losses, claims, damages, or liabilities (joint or several) to which any of
the foregoing persons may become subject, under the Act, the 1934 Act or other federal or state
law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereto) arise
out of or are based upon any Violation, in each case to the extent that such Violation occurs in
reliance upon and in conformity with written information furnished by Holder expressly for use in
connection with registration pursuant to the Shelf Registration Statement; and Holder will pay any
legal or other expenses reasonably incurred by any person intended to be indemnified pursuant to
this Section 2.7(b) in connection with investigating or defending any such indemnified loss, claim,
damage, liability or action; provided, however, that the indemnity agreement contained in this
Section 2.7(b) shall not apply to amounts paid in settlement of any such loss, claim, damage,
liability or action if such settlement is effected without the consent of Holder, which consent
shall not be unreasonably withheld, conditioned or delayed.

          (c) Promptly after receipt by an indemnified party under this Section 2.7 of notice of the
commencement of any action (including any governmental action), such indemnified party will, if a
claim in respect thereof is to be made against any indemnifying party under this Section 2.7,
deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying
party shall have the right to participate in, and, to the extent the indemnifying party so desires,
jointly with any other indemnifying party similarly noticed, to assume the defense thereof with
counsel mutually and reasonably satisfactory to the parties; provided, however, that an indemnified
party (together with all other indemnified parties which may be represented without conflict by one
counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid
by the indemnifying party, if representation of such indemnified party by the counsel retained by
the indemnifying party would be inappropriate due to actual or potential conflicts of interest
between such indemnified party and any other party represented by such counsel in such proceeding.
The failure to deliver written notice to the indemnifying party within a reasonable time of the
commencement of any such action, if prejudicial to its ability to defend such action, shall relieve
such indemnifying party, to the extent prejudiced, of any liability to the indemnified party under
this Section 2.7, but the omission to so deliver written notice to the indemnifying party will not
relieve it of any liability that it may have to any indemnified party otherwise than under this
Section 2.7.

          (d) If the indemnification provided for in this Section 2.7 is held by a court of competent
jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim,
damage, or expense referred to therein, then the indemnifying party, in lieu of indemnifying such
indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified
party as a result of such loss, liability, claim, damage, or expense in such proportion as is
appropriate to reflect the relative fault of the indemnifying party on the one hand and of the
indemnified party on the other in connection with the Violation that resulted in such loss,
liability, claim, damage, or expense as well as any other relevant equitable considerations. The
relative fault of the indemnifying party and of the indemnified party shall be determined by
reference to, among other things, whether the untrue or alleged Violation relates to information
supplied by the indemnifying party or by the indemnified party and the parties’ relative

6

 

intent, knowledge, access to information, and opportunity to correct or prevent such statement
or omission.

          (e) The obligations of UCBH and Holder under this Section 2.7 shall survive the completion of
any offer or sale of Registrable Shares pursuant to the Shelf Registration Statement.

     2.8 Prompt Notice of Suspension or Investigation. In the event any registration statement
filed by UCBH becomes subject to a stop order suspending its effectiveness, or proceedings for such
purpose are pending before or threatened by the SEC, UCBH shall provide the Company prompt notice
thereof.

          SECTION 3. TRANSFER OF REGISTRABLE SECURITIES AND ACQUISITION OF ADDITIONAL UCBH
SECURITIES

     3.1 Lock Up Agreement. Holder shall not, without the prior written consent of UCBH, (i)
offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option
or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise dispose of,
directly or indirectly, any Registrable Securities, or (ii) enter into any swap or other
arrangement that transfers to another, in whole or in part, directly or indirectly, any of the
economic consequences of ownership of such Registrable Securities, whether any such transaction
described in clause (i) or (ii) above (each, a “Transfer”) is to be settled by delivery of
securities, in cash or otherwise. Notwithstanding the foregoing, Holder may sell up to 100,000
shares of Registrable Securities each trading day in public market transactions only (a) pursuant
to the Shelf Registration Statement during the Shelf Effective Period, or (b) as permitted by and
pursuant to Rule 144 during the Shelf Effective Period or after the Shelf Effective Period;
provided that Holder shall use its commercially reasonable efforts to Transfer Registrable
Securities in an ordinary way that would not disrupt the public market for UCBH securities;
provided further that Holder may sell an unlimited number of shares of Registrable Securities
through Block Sales (as defined below) and that such sales shall not count against the 100,000
shares per day sales limit set forth above. An attempted Transfer in violation of this Agreement
shall be of no effect and null and void, regardless of whether the purported transferee has any
actual or constructive knowledge of the Transfer restrictions set forth in this Agreement, and
shall not be recorded on the stock transfer books of UCBH. No Transfer by Holder shall be
effective unless and until UCBH shall have been furnished with information reasonably satisfactory
to it demonstrating that such Transfer is in compliance with this Section 3. If the proposed
transfer complies with this Section 3, UCBH shall use its commercially reasonable efforts to assist
the Holder in effecting Block Sales of Registrable Securities. Dr. Huang shall not, without the
prior written consent of UCBH, (x) offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant
to purchase, lend, or otherwise dispose of, directly or indirectly, any of his record or beneficial
ownership interest in Company, or (y) enter into any swap or other arrangement that transfers to
another, in whole or in part, directly or indirectly, any of the economic consequences of his
record or beneficial ownership of Company, whether any such transaction described in clause (x) or
(y) above is to be settled by delivery of securities, in cash or otherwise. Dr. Huang represents
and warrants to UCBH that he is and that immediately after Closing he shall be the sole record and
beneficial owner of all of Company’s capital, of all voting interests in and with respect to
Company and of all of Company’s outstanding securities of any kind. For the purpose of this
Section 3, the term “Block Sales” means individual sale transactions of not less than 200,000
shares of Registrable Securities each at the latest reported market price in market or private
transactions approved in writing by UCBH in advance (such approval not to be unreasonably withheld,
conditioned or delayed).

     3.2 Legend on Shares. Each certificate representing Registrable Securities shall bear the
following restrictive legend:

7

 

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON
TRANSFERABILITY AND RESALE AS SET FORTH IN A REGISTRATION RIGHTS, LOCK UP, AND
STANDSTILL AGREEMENT, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE
COMPANY.

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS. THEY
MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A
REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER SUCH ACT OR
ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE
COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144
OF SUCH ACT.

     3.3 Acquisition of Additional UCBH Securities. Holder covenants and agrees with UCBH that
during the period of two (2) consecutive years commencing at the Closing, Holder shall not, and
shall cause each of Holder’s affiliates, and any spouse of Holder or any of their respective
relatives, not to, directly or indirectly, acquire, offer or propose to acquire or agree to
acquire, whether by purchase, tender or exchange offer, through the acquisition of control of
another person or entity (including by way of merger or consolidation), by joining a partnership,
syndicate or other group or otherwise, the beneficial ownership of any additional UCBH securities
of any kind (except by way of stock dividends, stock reclassifications or other distributions or
offerings made available and, if applicable, exercised on a pro rata basis, to holders of Common
Stock generally) without UCBH’s prior written consent. Holder represents and warrants to UCBH that
immediately after Closing Holder shall hold no record or beneficial ownership interest in any UCBH
securities other than the Registrable Securities.

          SECTION 4. OTHER PROVISIONS

     4.1 Effectiveness and Termination.

          (a) This Agreement shall become effective as of the date first above written and shall remain
in force and effect until the close of business on the last day of the Shelf Effective Period, at
which time this Agreement shall terminate; provided, however, that Section 2.5 (Reports under the
1934 Act) shall survive any termination of this Agreement and shall remain in full force and effect
throughout the earlier to end of the periods described in Section 2.5(a), Section 2.7
(Indemnification) shall survive such termination of this Agreement and shall remain in full force
and effect indefinitely, Section 3.1 (Lock Up Agreement) shall survive such termination of this
Agreement and shall remain in full force and effect throughout the period of two (2) consecutive
years commencing at the Closing, Section 3.3 (Acquisition of Additional UCBH Securities) shall
survive such termination of this Agreement and shall remain in full force and effect throughout the
period of two (2) consecutive years commencing at the Closing, and this Section 4 (Other
Provisions) shall survive such termination of this Agreement and shall remain in full force and
effect indefinitely.

          (b) This Agreement shall automatically terminate without any action on either party upon
termination of the Merger Agreement for any reason whatsoever, and notwithstanding anything
contrary contained herein, UCBH may withdraw the Shelf Registration Statement then on file with the
SEC. Upon termination of this Agreement pursuant to this Section 4.1(b), either party shall be
relieved from any of its obligations hereunder; provided that Section 2.3 shall survive to the
extent it is applicable and Section 4

8

 

(Other Provisions) shall survive such termination of this Agreement and shall remain in full
force and effect indefinitely.

     4.2 No Assignment. The parties’ respective rights and obligations pursuant to this Agreement
may not be transferred, assigned or delegated by either Holder or UCBH without the prior written
consent of the other. Any attempted transfer, assignment or delegation in violation of the
foregoing shall be void.

     4.3 Governing Law; Venue. This Agreement shall be governed by and construed in accordance
with the laws of the State of California, without reference to California’s conflict of law
principles. The venue for any action, suit or proceeding relating to or arising from this
Agreement shall be only a state or federal court of competent jurisdiction located in San
Francisco, California, and all objections to venue and personal jurisdiction in any action or
proceeding so commenced are hereby irrevocably waived.

     4.4 Counterparts. This Agreement may be executed in two or more counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same
instrument.

     4.5 Titles and Subtitle Verification. The titles and subtitles used in this Agreement are
used for convenience only and are not to be considered in construing or interpreting this
Agreement.

     4.6 Notices. All notices or other communications required or permitted hereunder shall be in
writing and shall be deemed effectively given: (i) upon personal delivery to the party to be
notified; (ii) when sent by confirmed electronic mail, with verification of receipt, or facsimile,
in either case if sent during normal business hours of the recipient; if not, then on the next
business day; (iii) three days after having been sent by registered or certified mail, return
receipt requested, postage prepaid; or (iv) one day after deposit with a nationally recognized
overnight courier, specifying next day delivery, with written verification of receipt. All
communications shall be sent to a party at such party’s address set forth on the signature page
hereof or at such other address, electronic or otherwise, as such party shall designate by ten
days’ advance written notice to the other party.

     4.7 Expenses. If any action at law or in equity is necessary to enforce the terms of this
Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and
necessary disbursements incurred in connection with such enforcement in addition to any other
relief to which such party may be entitled.

     4.8 Severability. If one or more provisions of this Agreement, together with the Merger
Agreement, are held to be unenforceable under applicable law, in whole or in part, the
unenforceable portion of such provision shall be excluded from this Agreement and the balance of
the Agreement shall be interpreted as if such unenforceable portion were so excluded and shall be
enforceable in accordance with its terms.

     4.9 Entire Agreement; Amendment; Waiver. This Agreement constitutes the full and entire
understanding and agreement between the parties hereto with regard to the subject matter hereof,
and supersedes any and all prior negotiations, correspondence, understandings and agreements among
the parties respecting the subject matter hereof. Any term of this Agreement may be amended and
the observance of any term of this Agreement may be waived (either generally or in a particular
instance and either retroactively or prospectively) only with the written consent of UCBH and
Holder.

[SIGNATURE PAGES FOLLOW]

9

 

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written.

	 	 	 	 	 	 	 
	 	 	UCBH HOLDINGS, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	/s/ Jonathan Downing 	 	 
	 

	 		 	 

	 	 
	 

	 	Name:	 	Jonathan Downing 	 	 
	 

	 		 	 

	 	 
	 

	 	Its:	 	Executive Vice President	 	 
	 

	 		 	 

	 	 
	 
	 	 	 	 	 	 
	 

	 	Address:
	 	555 Montgomery Street	 	 
	 

	 	 	 	San Francisco, CA 94111	 	 
	 
	 	 	 	 	 	 
	 

	 	E-mail:	 	 	 	 
	 

	 	Fax:
	 	 

	 	 
	 

	 	 	 	 

	 	 
	 
	 	 	 	 	 	 
	 	 	CAB INTERNATIONAL HOLDINGS LIMITED	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	/s/ Paul Shi H. Huang 	 	 
	 

	 	 	 	 

	 	 
	 

	 	Name:	 	Paul Shi H. Huang 	 	 
	 

	 	 	 	 

	 	 
	 

	 	Its:	 	Director	 	 

	 

	 	 	 	 

	 	 
	 
	 	 	 	 	 	 
	 

	 	Address:
	 	77 Bowery	 	 
	 

	 	 	 	New York, NY 10002	 	 
	 
	 	 	 	 	 	 
	 

	 	E-mail:	 	 	 	 
	 

	 	Fax:
	 	 

	 	 
	 

	 	 	 	 

	 	 
	 	 	DR. PAUL SHI H. HUANG	 	 
	 
	 	 	 	 	 	 
	 

	 	/s/ Paul Shi H. Huang 
	 	 	 	 	 
	 	 	Dr. Paul Shi H. Huang	 	 
	 
	 	 	 	 	 	 
	 

	 	Address:
	 	14th Floor, No.180, Chung Hsiao East
Road, Sec. 4	 	 
	 

	 	 	 	Taipei, Taiwan, Republic of China	 	 
	 
	 	 	 	 	 	 
	 

	 	E-mail:	 	 	 	 
	 

	 	 	 	 

	 	 
	 

	 	Fax:EX-10.1

 

Exhibit 10.1

SECOND AMENDMENT

     This Second Amendment (this “Amendment”) is entered into as of March 30, 2007,
by and among KENDLE INTERNATIONAL INC., an Ohio corporation (the “Borrower”), the Guarantors listed
on the signature pages hereof, the Lenders signatory hereto, and UBS AG, STAMFORD BRANCH, as
Administrative Agent for the Lenders (in such capacity, “Administrative Agent”).

RECITALS

     WHEREAS, the Borrower, the Guarantors, the Lenders, the Administrative Agent, UBS
SECURITIES LLC, as sole lead arranger and sole bookrunner, UBS AG, STAMFORD BRANCH, as issuing bank
and collateral agent, UBS LOAN FINANCE LLC, as swingline lender, JPMORGAN CHASE BANK, N.A., as
syndication agent, and KEYBANK NATIONAL ASSOCIATION, LASALLE BANK NATIONAL ASSOCIATION, and
NATIONAL CITY BANK, as co-documentation agents, are parties to that certain Credit Agreement dated
as of August 16, 2006, as amended by that certain First Amendment to Credit Agreement dated as of
December 11, 2006 (the “Credit Agreement”) (capitalized terms used herein without
definition have the meanings ascribed to such terms in the Credit Agreement);

     WHEREAS, the Borrower has requested certain amendments to the Credit Agreement; and

     WHEREAS, the Administrative Agent and the Required Lenders have agreed to amend the Credit
Agreement on the terms and subject to the conditions set forth herein.

     NOW THEREFORE, in consideration of the premises and the mutual covenants herein contained, the
parties hereto hereby agree as follows:

          Section 1. Section References. Unless otherwise expressly stated herein, all Section
references herein shall refer to Sections of the Credit Agreement.

          Section 2. Amendment to Section 1.01 (Defined Terms). Section 1.01 of the Credit Agreement is
hereby amended by:

               (a) inserting the following new defined terms in the appropriate alphabetical order therein:

          
“Convertible Debt Derivative Obligation” means any convertible debt hedge
transaction entered into in connection with a Convertible Debt Issuance, including any call options
related thereto and any related warrant transactions.

          “Second Amendment Effective Date” shall mean March 30, 2007.

               (b) amending clause (g) of the definition of “Consolidated Net Income” by inserting
the words “or Convertible Debt Derivative Obligations” immediately following the words “Hedging
Obligations” appearing in such clause.

35

 

               (c) amending clause (g) of the definition of “Indebtedness” by inserting the
words “and Convertible Debt Derivative Obligations” immediately following the words “Hedging
Obligations” appearing in such clause.

               (d) amending the definition of “Material Indebtedness” by (1) inserting a comma and
the words “Convertible Debt Derivative Obligations” immediately following the parenthetical
appearing in the first sentence of such definition, (2) inserting the words “Convertible Debt
Derivative Obligations or” immediately following the words “in respect of any” appearing in the
second sentence of such definition and (3) inserting the words “document evidencing such
Convertible Debt Derivative Obligations or the related” immediately following the word “related”
appearing in the second sentence of such definition.

               (e) amending clause (ix) of the definition of “Permitted Acquisition” by deleting
“$40.0 million” and replacing it with “$70.0 million.”

          Section 3. Amendment to Section 2.10(e) (Equity Issuance). Section 2.10(e) of the Credit
Agreement is hereby amended by inserting the following text immediately before the period at the
end of Section 2.10(e):

          “provided, further, no prepayments shall be required under this Section 2.10(e) with respect
to any Net Cash Proceeds resulting from any Convertible Debt Derivative Obligation or any part
thereof”

          Section 4. Amendments to Section 2.19(a) (Increase in Commitments). Section 2.19(a) of the
Credit Agreement is hereby amended by deleting “$15.0 million” and replacing it with “$30.0
million.”

          Section 5. Amendments to Section 6.01(c) (Indebtedness). Section 6.01(c) of the Credit
Agreement is hereby amended by inserting, immediately following the words “Indebtedness under” and
immediately preceding the words “Hedging Obligations” first appearing in such Section 6.01(c), the
words “Convertible Debt Derivative Obligations or.”

          Section 6. Amendments to Section 6.01(e) (Indebtedness). Section 6.01(e) of the Credit
Agreement is hereby amended by deleting “$20.0 million” in clause (ii) and replacing it with
“€35.0 million.”

          Section 7. Amendments to Section 6.04(d) (Investments, Loans and Advances). Section 6.04(d)
of the Credit Agreement is hereby amended by inserting, immediately following the words “Hedging
Obligations” appearing in such Section 6.04(d), the words “or Convertible Debt Derivative
Obligations.”

          Section 8. Amendments to Section 6.08 (Dividends). Section 6.08 of the Credit Agreement is
hereby amended as follows:

               (a) the word “and” at the end of clause (a) is hereby deleted;

               (b) the period at the end of clause (b) is hereby replaced with “; and”; and

               (c) the following text is inserted as clause “c”:

36

 

     “(c) Dividends payable by the Borrower in connection with any Convertible Debt Derivative
Obligation (including any payment required to terminate such Convertible Debt Derivative
Obligation).”

          Section 9. Amendments to Section 6.10 (Financial Covenants). Section 6.10 of the Credit
Agreement is hereby amended as follows:

               (a) clause (a) is hereby deleted in its entirety and replaced with the following:

     (a) Maximum Total Leverage Ratio. (i) So long as no Convertible Debt Issuance
has occurred, permit the Total Leverage Ratio, at any date during any period set forth in
the table below, to exceed the ratio set forth opposite such period in the table below:

	 	 	 	 	 
	Test Period	 	Leverage Ratio
	October 1, 2006 - December 31,
2006
	 	 	3.90 to 1.0	 
	January 1, 2007 - March 31, 2007
	 	 	4.25 to 1.0	 
	April 1, 2007 - June 30, 2007
	 	 	4.25 to 1.0	 
	July 1, 2007 - September 30, 2007
	 	 	3.85 to 1.0	 
	October 1, 2007 - December 31,
2007
	 	 	3.40 to 1.0	 
	January 1, 2008 - March 31, 2008
	 	 	3.25 to 1.0	 
	April 1, 2008 - June 30, 2008
	 	 	3.00 to 1.0	 
	July 1, 2008 - September 30, 2008
	 	 	2.90 to 1.0	 
	October 1, 2008 - December 31,
2008
	 	 	2.90 to 1.0	 
	January 1, 2009 - March 31, 2009
	 	 	2.25 to 1.0	 
	April 1, 2009 - June 30, 2009
	 	 	2.25 to 1.0	 
	July 1, 2009 - September 30, 2009
	 	 	2.00 to 1.0	 
	October 1, 2009 - December 31,
2009
	 	 	2.00 to 1.0	 
	January 1, 2010 - March 31, 2010
	 	 	1.75 to 1.0	 
	April 1, 2010 - June 30, 2010
	 	 	1.75 to 1.0	 
	July 1, 2010 - September 30, 2010
	 	 	1.60 to 1.0	 
	October 1, 2010 - December 31,
2010
	 	 	1.60 to 1.0	 
	January 1, 2011 and thereafter
	 	 	1.60 to 1.0	 

     (ii) On and after the occurrence of a Convertible Debt Issuance, permit the Total
Leverage Ratio, at any date during any period set forth in the table below, to exceed the
ratio set forth opposite such period in the table below:

37

 

	 	 	 	 	 
	Test Period	 	Leverage Ratio
	October 1, 2006 - December 31,
2006
	 	 	3.90 to 1.0	 
	January 1, 2007 - March 31, 2007
	 	 	4.95 to 1.0	 
	April 1, 2007 - June 30, 2007
	 	 	4.95 to 1.0	 
	July 1, 2007 - September 30, 2007
	 	 	4.50 to 1.0	 
	October 1, 2007 - December 31,
2007
	 	 	3.75 to 1.0	 
	January 1, 2008 - March 31, 2008
	 	 	3.75 to 1.0	 
	April 1, 2008 - June 30, 2008
	 	 	3.50 to 1.0	 
	July 1, 2008 - September 30, 2008
	 	 	3.25 to 1.0	 
	October 1, 2008 - December 31,
2008
	 	 	3.25 to 1.0	 
	January 1, 2009 - March 31, 2009
	 	 	2.25 to 1.0	 
	April 1, 2009 - June 30, 2009
	 	 	2.25 to 1.0	 
	July 1, 2009 - September 30, 2009
	 	 	2.00 to 1.0	 
	October 1, 2009 - December 31,
2009
	 	 	2.00 to 1.0	 
	January 1, 2010 - March 31, 2010
	 	 	1.75 to 1.0	 
	April 1, 2010 - June 30, 2010
	 	 	1.75 to 1.0	 
	July 1, 2010 - September 30, 2010
	 	 	1.60 to 1.0	 
	October 1, 2010 - December 31,
2010
	 	 	1.60 to 1.0	 
	January 1, 2011 and thereafter
	 	 	1.60 to 1.0	 

               (b) clause (b) is hereby deleted in its entirety and replaced with the following:

     (b) Minimum Interest Coverage Ratio. (i) So long as no Convertible Debt
Issuance has occurred, permit the Consolidated Interest Coverage Ratio, for any Test
Period ending during any period set forth in the table below, to be less than the ratio
set forth opposite such period in the table below:

	 	 	 	 	 
	 	 	Interest
	Test Period	 	Coverage Ratio
	October 1, 2006 - December 31, 2006
	 	 	3.00 to 1.0	 
	January 1, 2007 - March 31, 2007
	 	 	2.70 to 1.0	 
	April 1, 2007 - June 30, 2007
	 	 	2.70 to 1.0	 
	July 1, 2007 - September 30, 2007
	 	 	3.10 to 1.0	 
	October 1, 2007 - December 31,
2007
	 	 	3.25 to 1.0	 
	January 1, 2008 - March 31, 2008
	 	 	3.40 to 1.0	 

38

 

	 	 	 	 	 
	 	 	Interest
	Test Period	 	Coverage Ratio
	April 1, 2008 - June 30, 2008
	 	 	3.40 to 1.0	 
	July 1, 2008 - September 30, 2008
	 	 	3.75 to 1.0	 
	October 1, 2008 - December 31, 2008
	 	 	4.00 to 1.0	 
	January 1, 2009 - March 31, 2009
	 	 	4.00 to 1.0	 
	April 1, 2009 - June 30, 2009
	 	 	4.00 to 1.0	 
	July 1, 2009 - September 30, 2009
	 	 	4.25 to 1.0	 
	October 1, 2009 - December 31, 2009
	 	 	4.25 to 1.0	 
	January 1, 2010 - March 31, 2010
	 	 	4.75 to 1.0	 
	April 1, 2010 - June 30, 2010
	 	 	4.75 to 1.0	 
	July 1, 2010 - September 30, 2010
	 	 	5.00 to 1.0	 
	October 1, 2010 - December 31, 2010
	 	 	5.00 to 1.0	 
	January 1, 2011 and thereafter
	 	 	5.00 to 1.0	 

     (ii) Following the occurrence of a Convertible Debt Issuance, permit the
Consolidated Interest Coverage Ratio, for any Test Period beginning with the first day of
the fiscal quarter following the fiscal quarter in which such Convertible Debt Issuance
occurred and ending during any period set forth in the table below, to be less than the
ratio set forth opposite such period in the table below:

	 	 	 	 	 
	 	 	Interest
	Test Period	 	Coverage Ratio
	October 1, 2006 - December 31,
2006
	 	 	3.00 to 1.0	 
	January 1, 2007 - March 31, 2007
	 	 	3.00 to 1.0	 
	April 1, 2007 - June 30, 2007
	 	 	3.00 to 1.0	 
	July 1, 2007 - September 30, 2007
	 	 	3.40 to 1.0	 
	October 1, 2007 - December 31,
2007
	 	 	3.40 to 1.0	 
	January 1, 2008 - March 31, 2008
	 	 	3.40 to 1.0	 
	April 1, 2008 - June 30, 2008
	 	 	3.40 to 1.0	 
	July 1, 2008 - September 30, 2008
	 	 	3.75 to 1.0	 
	October 1, 2008 - December 31,
2008
	 	 	4.00 to 1.0	 
	January 1, 2009 - March 31, 2009
	 	 	4.00 to 1.0	 
	April 1, 2009 - June 30, 2009
	 	 	4.00 to 1.0	 
	July 1, 2009 - September 30, 2009
	 	 	4.25 to 1.0	 
	October 1, 2009 - December 31,
2009
	 	 	4.25 to 1.0	 

39

 

	 	 	 	 	 
	 	 	Interest
	Test Period	 	Coverage Ratio
	January 1, 2010 - March 31, 2010
	 	 	4.75 to 1.0	 
	April 1, 2010 - June 30, 2010
	 	 	4.75 to 1.0	 
	July 1, 2010 - September 30, 2010
	 	 	5.00 to 1.0	 
	October 1, 2010 - December 31,
2010
	 	 	5.00 to 1.0	 
	January 1, 2011 and thereafter
	 	 	5.00 to 1.0	 

          Section 10. Amendments to Section 8.01(f) (Events of Default). Section 8.01(f) of the Credit
Agreement is hereby amended by deleting the end of such Section 8.01(f) starting with the words
“provided that” and replacing it with the following:

          “provided that, in the case of Convertible Debt Derivative Obligations or Hedging Obligations,
the amount counted to determine if such Convertible Debt Derivative Obligations or Hedging
Obligations constitute Material Indebtedness shall be the amount payable by all Companies if such
Convertible Debt Derivative Obligations or Hedging Obligations, as applicable, were terminated at
such time;”

          Section 11. Amended and Restated UK Charge Over Shares. The Required Lenders agree that the
UK Charge Over Shares granted by Kendle NC Inc. in favor of UBS, Stamford Branch, as Collateral
Agent, shall be amended and restated in the form attached hereto as Exhibit A.

          Section 12. Conditions Precedent. The effectiveness of this Amendment is subject to the
satisfaction of each of the following conditions precedent:

               (a) The Administrative Agent shall have received all of the following, in form and substance
satisfactory to the Administrative Agent:

               (i) Amendment Documents. This Amendment, duly executed by the Borrower and
the Guarantors, and the Amended and Restated UK Charge Over Shares, duly executed
by Kendle NC Inc. (the “Amendment Documents”);

               (ii) Consent of Required Lenders. The written consent of the Required
Lenders to this Amendment; and

               (iii) Additional Information. Such additional documents, instruments and
information as the Administrative Agent may reasonably request to effect the
transactions contemplated hereby.

               (b) The representations and warranties contained herein and in the Credit Agreement shall be
true and correct in all material respects as of the date hereof as if made on the date
hereof (except for those which by their terms specifically refer to an earlier date, in which case
such representations and warranties shall be true and correct in all material respects as of such
earlier date).

40

 

               (c) All corporate proceedings taken in connection with the transactions contemplated by this
Amendment and all other agreements, documents and instruments executed or delivered pursuant
hereto, and all legal matters incident thereto, shall be reasonably satisfactory to the
Administrative Agent.

               (d) No Default or Event of Default shall have occurred and be continuing, after giving effect
to this Amendment.

               (e) The Borrower shall have paid an amendment fee to each Lender that consents to this
Amendment by 5:00 p.m., New York City time, on Thursday, March 29, 2007, equal to 0.15% of such
Lender’s outstanding Loans and Commitments immediately prior to the Second Amendment Effective Date
(the “Amendment Fee”), such Amendment Fee to be due and payable on the Second Amendment Effective
Date.

          Section 13. Representations and Warranties. The Borrower hereby represents and warrants to
the Administrative Agent and the Lenders that, as of the date of and after giving effect to this
Amendment, (a) the execution, delivery and performance of this Amendment and any and all other
Amendment Documents executed and/or delivered in connection herewith have been authorized by all
requisite corporate action on the part of the Borrower or any other Loan Party and will not violate
such Loan Party’s Organizational Documents, (b) all representations and warranties set forth in the
Credit Agreement and in any other Loan Document are true and correct in all material respects as if
made again on and as of such date (except those, if any, which by their terms specifically relate
only to an earlier date, in which case such representations and warranties are true and correct in
all material respects as of such earlier date), and (c) no Default or Event of Default has occurred
and is continuing.

          Section 14. Survival of Representations and Warranties. All representations and warranties
made in this Amendment or any other Loan Document shall survive the execution and delivery of this
Amendment and the other Loan Documents, and no investigation by the Administrative Agent or the
Lenders, or any closing, shall affect the representations and warranties or the right of the
Administrative Agent and the Lenders to rely upon them.

          Section 15. Certain Waivers. Each of the Borrower and the Guarantors hereby agrees that
neither the Administrative Agent nor any Lender shall be liable under a claim of, and hereby waives
any claim against the Administrative Agent and the Lenders based on, lender liability (including,
but not limited to, liability for breach of the implied covenant of good faith and fair dealing,
fraud, negligence, conversion, misrepresentation, duress, control and interference, infliction of
emotional distress and defamation and breach of fiduciary duties) as a result of the amendments
contained in Sections 2, 3, 4, 5, 6, 7, 8, 9, 10 and 11 above and any discussions or actions taken
or not taken by the Administrative Agent or the Lenders on or before the date hereof or the
discussions conducted in connection therewith, or any course of action taken by the Administrative
Agent or any Lender in response thereto or arising therefrom; provided, that the foregoing waiver
shall not include the waiver of any claims which are based on the gross
negligence or willful misconduct of the Administrative Agent or any Lender or any of their
respective agents. This Section 15 shall survive the execution and delivery of this Amendment and
the other Loan Documents and the termination of the Credit Agreement.

          Section 16. Reference to Agreement. Each of the Loan Documents, including the Credit
Agreement, and any and all other agreements, documents or instruments now or hereafter executed
and/or delivered pursuant to the terms hereof or pursuant to the terms of the

41

 

Credit Agreement as
amended hereby, are hereby amended so that any reference in such Loan Documents to the Credit
Agreement, whether direct or indirect, shall mean a reference to the Credit Agreement as amended
hereby.

          Section 17. Costs and Expenses. The Borrower shall pay on demand all reasonable out-of-pocket
costs and expenses of the Administrative Agent (including the reasonable fees, costs and expenses
of counsel to the Administrative Agent) incurred in connection with the preparation, execution and
delivery of this Amendment.

          Section 18. Governing Law. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE
WITH, THE LAWS OF THE STATE OF NEW YORK.

          Section 19. Headings. Section Headings in this Amendment are included herein for convenience
of reference only and shall not constitute a part of this Amendment for any other purposes.

          Section 20. Execution. This Amendment may be executed in any number of counterparts and by
different parties hereto in separate counterparts, each of which when so executed shall be deemed
to be an original and all of which taken together shall constitute one and the same agreement.
Delivery of an executed counterpart of a signature page to this Amendment by telecopier shall be
effective as delivery of a manually executed counterpart of this Amendment.

          Section 21. Limited Effect. This Amendment relates only to the specific matters covered
herein, shall not be considered to be a waiver of any rights any Lender may have under the Credit
Agreement (other than as expressly set forth herein), and shall not be considered to create a
course of dealing or to otherwise obligate any Lender to execute similar amendments under the same
or similar circumstances in the future.

          Section 22. Ratification By Guarantors. Each Guarantor hereby agrees to this Amendment, and
each Guarantor acknowledges that such Guarantor’s Guarantee shall remain in full force and effect
without modification thereto.

[signature pages follow]

42

 

          IN WITNESS WHEREOF, the parties hereto have caused this amendment to be executed by their
respective officers thereunto duly authorized, as of the date first above written.

	 	 	 	 	 
	 	KENDLE INTERNATIONAL INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	 	ACER/EXCEL INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	 	AAC CONSULTING GROUP, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	 	KENDLE INTERNATIONAL CPU LLC

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	 	KENDLE AMERICAS HOLDING INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

 

 

	 	 	 	 	 
	 	KENDLE AMERICAS INVESTMENT INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	KENDLE AMERICAS MANAGEMENT INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	KENDLE DELAWARE INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	KENDLE NC INC. 

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	KENDLE CLINICAL DEVELOPMENT SERVICES LIMITED

(formerly known as Charles River Laboratories
Clinical Services International Ltd.)

 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	UBS AG, STAMFORD BRANCH,

as Administrative Agent

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

 

 

	 	 	 	 	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	 	LENDERS:

 	
, 
	 	
as a Lender

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}]]